Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Рекордати Айрленд ЛимитедfiledCriticalРекордати Айрленд Лимитед
Publication of UA89177C2publicationCriticalpatent/UA89177C2/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Medicinal Preparation
(AREA)
Abstract
A controlled release pharmaceutical composition comprising lercanidipine dissolved or dispersed in a solid vehicle at ambient temperature, thus forming a solid dispersion, achieves delayed release of lercanidipine over an extended period of time, reduced food effect and increased bioavailability compared to commercially available lercanidipine containing products.
1h- and 1-methyl-3,4-dihydro-2,5-dioxo-3-(pyrid-4-yl-p-phenylmethyl)-4h-l,4-benzodiazepine halosubstituted derivatives, pharmaceutical compositions comprising them and methods for regulating cell death using them